Smith & Nephew PLC (SN)

1,410.50
+1.00(+0.07%)
  • Volume:
    504,649
  • Bid/Ask:
    1,410.00/1,411.00
  • Day's Range:
    1,399.50 - 1,422.00

SN Overview

Prev. Close
1,409.5
Day's Range
1,399.5-1,422
Revenue
5.24B
Open
1,418.5
52 wk Range
1,317-1,681.5
EPS
0.45
Volume
504,649
Market Cap
12.38B
Dividend (Yield)
27.07
(1.88%)
Average Volume (3m)
1,898,084
P/E Ratio
31.14
Beta
0.74
1-Year Change
-8.8%
Shares Outstanding
878,006,213
Next Earnings Date
04 Nov 2021
What is your sentiment on Smith & Nephew PLC?
or
Vote to see community's results!

Smith & Nephew PLC News

Smith & Nephew PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellSell
Technical IndicatorsStrong SellStrong BuyStrong SellStrong SellStrong Sell
SummarySellNeutralStrong SellStrong SellStrong Sell

Smith & Nephew PLC Company Profile

Smith & Nephew PLC Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Read More
  • Load up.
    0
    • Guuuud-bye inflation. No but seriously this a good buy to hedge against inflation.
      0
      • Good buy
        0
        • set buy target 1100
          3
          • just wonder why the sentiment is not bullish? reversal? don't think so
            0
            • bet you got wiped out hah?
              0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.